Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas J Lowe

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Journal of the American Academy of Dermatology|August 2, 2003
Current systemic therapies for psoriasis: where are we now?Paul S Yamauchi, Dalia Rizk, Tanya Kormeili, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|September 25, 2002
Efficacy and safety of botulinum toxin type a in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled studyNicholas J Lowe, Paul S Yamauchi, Gary P Lask, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 22, 2005
Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow's feetNicholas J Lowe, Benjamin Ascher, Marc Heckmann, et al.
Journal of the American Academy of Dermatology|February 21, 2006
Treatment of recurrent Sweet's syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanerceptPaul S Yamauchi, Logan Turner, Nicholas J Lowe, et al.
Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology|June 25, 2002
Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosingNicholas J Lowe, Paul S Yamauchi, Gary P Lask, et al.
Journal of the American Academy of Dermatology|February 20, 2007
Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safetyNicholas J Lowe, Dee Anna Glaser, Nina Eadie, et al.
Current Problems in Dermatology|October 26, 2021
Assessment of Natural Sunlight Protection Provided by 10 High-SPF Broad-Spectrum Sunscreens and Sun-Protective FabricsShaun N G Hughes, Nicholas J Lowe, Ken Gross, et al.
Journal of the American Academy of Dermatology|June 14, 2002
A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar linesJ Alastair Carruthers, Nicholas J Lowe, M Alan Menter, et al.
Journal of the American Academy of Dermatology|July 29, 2004
Recognition, diagnosis, and treatment of primary focal hyperhidrosisJohn Hornberger, Kevin Grimes, Markus Naumann, et al.
Journal of the American Academy of Dermatology|February 13, 2003
Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trialDavid M Pariser, Nicholas J Lowe, Daniel M Stewart, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Journal of the American Academy of Dermatology|August 2, 2003
Current systemic therapies for psoriasis: where are we now?Paul S Yamauchi, Dalia Rizk, Tanya Kormeili, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|September 25, 2002
Efficacy and safety of botulinum toxin type a in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled studyNicholas J Lowe, Paul S Yamauchi, Gary P Lask, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 22, 2005
Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow's feetNicholas J Lowe, Benjamin Ascher, Marc Heckmann, et al.
Journal of the American Academy of Dermatology|February 21, 2006
Treatment of recurrent Sweet's syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanerceptPaul S Yamauchi, Logan Turner, Nicholas J Lowe, et al.
Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology|June 25, 2002
Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosingNicholas J Lowe, Paul S Yamauchi, Gary P Lask, et al.
Journal of the American Academy of Dermatology|February 20, 2007
Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safetyNicholas J Lowe, Dee Anna Glaser, Nina Eadie, et al.
Current Problems in Dermatology|October 26, 2021
Assessment of Natural Sunlight Protection Provided by 10 High-SPF Broad-Spectrum Sunscreens and Sun-Protective FabricsShaun N G Hughes, Nicholas J Lowe, Ken Gross, et al.
Journal of the American Academy of Dermatology|June 14, 2002
A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar linesJ Alastair Carruthers, Nicholas J Lowe, M Alan Menter, et al.
Journal of the American Academy of Dermatology|July 29, 2004
Recognition, diagnosis, and treatment of primary focal hyperhidrosisJohn Hornberger, Kevin Grimes, Markus Naumann, et al.
Journal of the American Academy of Dermatology|February 13, 2003
Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trialDavid M Pariser, Nicholas J Lowe, Daniel M Stewart, et al.
Pageof 6